Resilience for future pandemics requires increased research and development, sustained vaccine manufacturing capabilities and global public–private collaboration.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Silva, S., Goosby, E. & Reid, M. J. A. Scientific Reports 13, 3065 (2023).
Kupcova, I., Danisovic, L., Klein, M. & Harsanyi, S. BMC Psychology 11, 108 (2023).
Marani, M., Katul, G. G., Pan, W. K. & Parolari, A. J. Proc. Natl Acad. Sci. USA 118, e2105482118 (2021).
Le, T. T. et al. Nat. Rev. Drug Discov. 19, 305–06 (2020).
Verbeke, R., Lentacker, I., De Smedt, S. C. & Dewitte, H. J. Control. Release 333, 511–520 (2021).
Dolgin, E. Nature 597, 318–324 (2021).
Rabaan, A. A. et al. Infez. Med. 28, 174–184 (2020).
Crommelin, D. J. A., Anchordoquy, T. J., Volkin, D. B., Jiskoot, W. & Mastrobattista, E. J. Pharmaceut. Sci. 110, 997–1001 (2021).
Sell, T. K. et al. Vaccine 39, 1667 (2021).
Dzau, V. J., Balatbat, C. A. & Offodile, A. C. 2nd Lancet 399, 1924–1926 (2022).
Bollyky, T. J. & Bown, C. P. Foreign Aff. 99, 96 (2020).
Taylor, A. The Washington Post https://go.nature.com/47dETAj (2022).
Usher, A. D. The Lancet 397, 2322–2325 (2021).
Peters, R. & Prabhakad, D. UNCTAD News https://go.nature.com/3sblzoC (2021).
Pfizer Inc. Press release. https://go.nature.com/3QHiea1 (2021).
Acknowledgements
We thank M. Beitelshees for editorial support and review in preparing this article.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
B.A.W., C.H.J., V.W. and J.M.T. report that they are employees of Pfizer Inc. and may hold stock or stock options in the company. Editorial support was provided by M. Beitelshees at Bulmore Consulting, and this support was funded by Pfizer.
Rights and permissions
About this article
Cite this article
Williams, B.A., Jones, C.H., Welch, V. et al. Pandemic preparedness requires collaboration between governments, funders and pharma. Nat Med 29, 2999–3001 (2023). https://doi.org/10.1038/s41591-023-02664-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02664-2